FibroGen, Inc. (FGEN)

R&D Expenses

$22.86M

TTM · Period ending: · USD

FGEN logo

FGEN R&D Expenses

Latest reported$22.86M
FGEN TTM R&D Expenses ($85.71M → $22.86M)
High-resolution chart · PNG

FGEN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

FibroGen, Inc. R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
22,864,000
21,908,000
23,517,000
17,735,000
38,234,000
64,729,000
92,043,000
142,260,000
181,746,000
244,864,000
282,861,000
292,786,000
306,774,000
282,259,000
296,791,000
349,083,000
349,781,000
401,385,000
387,043,000
351,255,000
333,851,000
272,698,000
252,924,000
231,589,000
223,076,000
213,670,000
209,264,000
222,751,000
229,231,000
229,361,000
235,839,000
218,024,000
211,917,000
206,760,000
196,518,000
194,656,000
184,878,000
190,289,000
187,207,000
196,524,000
208,037,000
207,200,000
214,089,000
205,423,000
193,969,000
175,683,000
150,794,000
128,970,000
111,537,000
96,291,000
85,710,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.